<DOC>
	<DOC>NCT01107353</DOC>
	<brief_summary>The objective of this study was to prove the bioequivalence of Imipramine Pamoate 75 mg Capsules under fasting conditions</brief_summary>
	<brief_title>Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Imipramine</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to imipramine pamoate or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>